Oral Drug
- All
- News
- Videos
-
Weight Loss Pill Wegovy Now Available On Amazon Pharmacy In The U.S.
Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical therapy from consumer health products.
-
First Oral Pill For Adults With Thalassemia Anaemia Gets Approval, Experts Hail It As Game Changer
The US Food and Drug Administrations (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks a historic milestone and can be a game changer in the management of the genetic blood disorder, said
-
Centre Bans High-Dose Nimesulide Oral Drugs Over Health Risk Concerns
The Centre has banned oral nimesulide formulations above 100 mg with immediate effect, citing potential health risks and the availability of safer alternatives. The move, taken under the Drugs and Cosmetics Act, applies nationwide.
-
Health Ministry Bans Nimesulide Oral Doses Above 100 Mg Over Safety Concerns
The government has banned the manufacture, sale and distribution of all oral formulations of pain and fever medications, containing Nimesulide above 100 milligrams in immediate release dosage form, with immediate effect.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Explained: How An Acne Drug Can Treat Male Pattern Baldness
New 2025 study results show Clascoterone, originally approved for acne, could be the first new effective topical for male pattern baldness in 30 years. Its androgen-blocking action may restore hair growth while avoiding systemic side-effects of oral
-
New Experimental Drug Enlicitide May Cut "Bad" Cholesterol By Up To 60%
A new daily oral medication, enlicitide, has shown reductions in LDL cholesterol of up to 60% in a late-stage Phase 3 trial, matching the efficacy of injectable PCSK9 inhibitors.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
Baby Successfully Treated For Deadly Motor Neuron Diseases While Still In Womb
The mother took the drug daily for six weeks while the baby herself was given the drug orally, roughly one week after the birth.
-
New Drug 95% Effective Against Sleeping Sickness In Adults: Lancet Study
A new, single-dose oral treatment for sleeping sickness is 95 per cent effective in adults and adolescents, regardless of disease stage, according to a study published in The Lancet Infectious Diseases.
-
Maharashtra Orders Sample Checks On All Syrups After WHO Alert: Report
The drug regulator of Maharashtra has ordered sample checks on all oral liquid solutions in the state, asking for reports on the levels of diethylene glycol and ethylene glycol, CNBC TV18 reported on Thursday.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
Hyderabad Firm Seeks Approval To Produce Generic Merck Covid Pill
The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.
-
Weight Loss Pill Wegovy Now Available On Amazon Pharmacy In The U.S.
Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical therapy from consumer health products.
-
First Oral Pill For Adults With Thalassemia Anaemia Gets Approval, Experts Hail It As Game Changer
The US Food and Drug Administrations (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks a historic milestone and can be a game changer in the management of the genetic blood disorder, said
-
Centre Bans High-Dose Nimesulide Oral Drugs Over Health Risk Concerns
The Centre has banned oral nimesulide formulations above 100 mg with immediate effect, citing potential health risks and the availability of safer alternatives. The move, taken under the Drugs and Cosmetics Act, applies nationwide.
-
Health Ministry Bans Nimesulide Oral Doses Above 100 Mg Over Safety Concerns
The government has banned the manufacture, sale and distribution of all oral formulations of pain and fever medications, containing Nimesulide above 100 milligrams in immediate release dosage form, with immediate effect.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Explained: How An Acne Drug Can Treat Male Pattern Baldness
New 2025 study results show Clascoterone, originally approved for acne, could be the first new effective topical for male pattern baldness in 30 years. Its androgen-blocking action may restore hair growth while avoiding systemic side-effects of oral
-
New Experimental Drug Enlicitide May Cut "Bad" Cholesterol By Up To 60%
A new daily oral medication, enlicitide, has shown reductions in LDL cholesterol of up to 60% in a late-stage Phase 3 trial, matching the efficacy of injectable PCSK9 inhibitors.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
Baby Successfully Treated For Deadly Motor Neuron Diseases While Still In Womb
The mother took the drug daily for six weeks while the baby herself was given the drug orally, roughly one week after the birth.
-
New Drug 95% Effective Against Sleeping Sickness In Adults: Lancet Study
A new, single-dose oral treatment for sleeping sickness is 95 per cent effective in adults and adolescents, regardless of disease stage, according to a study published in The Lancet Infectious Diseases.
-
Maharashtra Orders Sample Checks On All Syrups After WHO Alert: Report
The drug regulator of Maharashtra has ordered sample checks on all oral liquid solutions in the state, asking for reports on the levels of diethylene glycol and ethylene glycol, CNBC TV18 reported on Thursday.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
Hyderabad Firm Seeks Approval To Produce Generic Merck Covid Pill
The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.
